Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Did the float just got smaller? I cant remember.
JMO
Trust me. Guys like Gilead, J&J, Pfizer, and the like are watching. These guys are flush with cash to buy something to help it’s shareholders. None of big pharma outside of Gilead create new stuff. They all are on a buying spree
They see and know all.
Positive trial news and the big boys pounce with their $Billions
Time to buy and hold is now. I wouldn’t put the entire second mortgage in this, but holy crap if you did? American dream
Agreed on all accounts. This is going to be HUGE imo..
Amazed that no one has caught onto this yet...
Holy smokes! I didn't see that until just now. That is HUGE. Monster run coming imo
ALZX is an open symbol.
Alzex Biomedical Group Inc.
https://alzex.ca/
ALZEX NEUROPHARMA INC
https://opencorporates.com/companies/us_nv/E27179052022-5
IMO
With this share structure, we could hit $100. I have seen short squeezes really come into play on these minuscule structures especially when doing a name/symbol change as all the shorts have to be covered and accounted by the transfer agent! That means we got one hell of a run coming here boys and girls!!!!
Trinity Resources Inc. Awaiting Regulatory Approval of Name and Symbol Change
Newsfile Corp.
Las Vegas, Nevada--(Newsfile Corp. - December 16, 2022) - TRINITY RESOURCES INC. (OTC Pink: TRRI) (the "Company" or "Trinity") announces that further to its news release on August 29, 2022, it has applied for name and symbol change to reflect its new name of ALZEX NEUROPHARMA INC. and is awaiting final approval from FINRA of its Corporate Action.
In August, the Company completed its end of the terms of the binding Asset Purchase Agreement (the "Agreement") whereby it has acquired all of the assets and intellectual property (the "Assets") of Alzex Biomedical Group Inc. Pursuant to the terms of the Agreement, Trinity issued ten million (10,000,000) restricted shares of Trinity's Series A Convertible Preferred Stock to Alzex Biomedical Group Inc. Trinity will also advance the sum of one hundred and fifty thousand dollars ($150,000 USD), to be disbursed by mutual agreement within the Alzex team, to settle certain outstanding liabilities of Alzex as well as to further secure and refile additional patent protection covering the acquired intellectual property. The shareholders of Trinity's Series A Convertible Preferred Stock will retain security over the intellectual property until Trinity has successfully raised the first five million dollars ($5,000,000 USD) that shall be deployed towards the pre-clinical and clinical development of the acquired Alzex assets, at which point the preferred shares will automatically convert into common shares on a one-to-one basis. If shareholders of Alzex have not already done so, they should contact Transhare Corporation, the Company's transfer agent of record, at (303) 662-1112 to provide their individual shareholder information so their shares of Series A Convertible Preferred Stock may be held in their names.
Alzex Biomedical Group Inc. is a Canadian based development stage biopharmaceutical company which has developed and patented precision therapeutics for the treatment of Alzheimer's Disease and other neurological diseases. It currently holds two families of patents via an exclusive and unlimited licensing agreement with INSA (Institut National des Sciences Appliquées) a major French academic engineering and research institute.
Alzex Biomedical Group Inc. has devised an innovative therapeutic approach aimed at treating brain diseases by means of highly selective bio precursor drugs (prodrugs). The validity of this approach is evidenced by the company's progress on Alzheimer's Disease. The company has developed and patented two families of this new class of drugs, for which "proof of concept" in animal trials (in-vitro) has been established.
This new class of drugs do not deploy any biological activity before they have crossed the blood-brain barrier, and hence do not induce significant side effects. The therapy can then target specific receptor sites in a more selective way, forming a superior delivery system through the blood-brain barrier.
The therapy can then target specific receptor sites in a more selective way, forming a superior delivery system through the blood-brain barrier. This technology could potentially be applied to any number of brain diseases.
Forward-Looking Statements:
This release includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. Such statements include any that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words "estimate", "project", "intend", "forecast", "anticipate", "plan", "planning", "expect", "believe", "likely", "should", "could", "would", "may" or similar words or expressions. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the Company's actual results and financial position to differ materially from those in such statements, which involve risks and uncertainties, including those relating to the Company's ability to grow. Actual results may differ materially from those predicted and any reported should not be considered an indication of future performance. Potential risks and uncertainties include the Company's operating history and resources, together with all usual and common economic, competitive, and equity market conditions / risks.
Contact:
Robert Rosner, President
Trinity Resources Inc.
info@trinresinc.com
www.trinresinc.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/148454
SOURCE Trinity Resources Inc.
https://api.newsfilecorp.com/newsinfo/148454/130
Here is the link! This merger is done....
https://www.otcmarkets.com/stock/TRRI/news/story?e&id=2407721
TRRI news update after hours Friday.,
More house cleaning chores getting done.
Name and symbol change paper work is in.
This shell is no longer get a shell.
Great color. Thanks!
I just looked on Twitter and their web site..
Nothing.
I was going to search some of the guys that got preferred shares to see who actually own this.
There is one pharma company listed. That’s a great sign. Probably the sales and marketing arm when this get approved.
It’s in the last disclosures filing. The next one is the one I’ll savor.
Anything new from the company lately? This will FLY when they talk
Got some .2251s with the ash tray money left in my account.
I might get a few more ghost orders on the BID side for this tax loss season.
I’m going to ride this till the float #s start to change. Till then, I’ll continue to take these kicks to the nutz and keep adding.
I still think the right news and we are over $2.50-$3.00+
The Company being quiet since the R/M ain’t helping anyone but us that continue to blindly add.
This is on the LAUNCHPAD!!
An oz of prevention is worth a pound of cure.
https://link.theepochtimes.com/mkt_app/health/adding-cinnamon-to-your-daily-diet-can-prevent-alzheimers-disease_4847243.html
You and me both…,
I’m still nipping away at my average.
Got a few 100 more to help the cause today.
I’m still below a 5% holder. Killed my average In The beginning by loading up an a good few $1+ shares.
This is thin.,
Not me I got plenty
Who got those .399s?
I was about to slap for a few 100 to round up my stack. LOL
Nice buying today. This ticker is ready to blow
House cleaning chores done. SS remains the same.
https://www.otcmarkets.com/otcapi/company/financial-report/354749/content
Under a 500k float. Insane numbers.
September Q hit...should be current soon
https://www.bloomberg.com/news/articles/2018-06-12/lilly-astrazeneca-end-trials-as-alzheimer-drug-shows-no-promise?leadSource=uverify%20wall
But Lilly has that new weight loss injections used for Type2. My sister lost 60 pounds. They are going to make $Billions on the fat side of things.
TRRI trugs along. They need to get their Atty letter in to get back to Pink Current. Great time for ETraders to buy.
I’m still rolling the dice here.,
https://alzex.ca/
At least it’s E*trade on the Ask. Retail gets bored. I’d love to take his 2500 shares.
TRRI has been way too quiet. This one is killing me. Down $5k
I should get some more $$ on the BID for paper tax loss season
It get confused once I have many stock start with T.
LOL
IMO
No worries. I just got excited for potential news…
Woops.. Wrong board.. My bad.
IMO
It’s a new thing for those eggheads. They will get the house cleaning done.
Like the rich guy buying his first jet. It’s a bit overwhelming sitting in the drivers seat. You realize very fast your going to need some help.
How they couldn't file in a timely fashion is beyond me
TRRI did not get their Atty letter in, lost Pink Current.
Might be a great time to get some cash in the BID to catch a few knee jerk shares on the cheap.,
TRRI will get this house cleaning chute done. Probably a low priority today.
Once $2.39 breaks, the sky is the limit
I have a good feeling here... .428
Definitely extremely low float here
No shares for retail. Float is owned and can explode any trading day.
$3.50 -$5.00 easy on any update. I think $2.50 is a given.
We are getting close and this thing will get closer to $5 this time….
I’m hoping over .50 we see the few give up shares on the BID again.
MMs will be crazy to sell vapor shares in this at these prices.
Just takes one whale to have to have 100k below $2.50
Getting there.
IMO
This is going to blow up imo... Less than 500k in the float
Looks like the float is locked up.
First slap took out a ghost order,
Second slap hit the Ask.
Easy to run it up with this float.
Under 450k
News will be an epic run when it comes. This is where you want to be loading
Nice little buying action today. This spike might work a few shares lose into the BID, but I’m not confident any shares will be given up like that.
I did slap @.42 for a grand MMs gave me .35+
Followers
|
166
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
14798
|
Created
|
12/13/08
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |